Copyright
©The Author(s) 2005.
World J Gastroenterol. Aug 14, 2005; 11(30): 4753-4757
Published online Aug 14, 2005. doi: 10.3748/wjg.v11.i30.4753
Published online Aug 14, 2005. doi: 10.3748/wjg.v11.i30.4753
Table 1 Distribution of HLA-DRB1*03,*07,*09,*12,*15 alleles in patients with chronic hepatitis B and healthy controls
| DRB1*Allele | Chronic hepatitis (n = 126) | Normal control (n = 76) | RR | χ2 | P | ||
| PN | PR (%) | PN | PR (%) | ||||
| 0301/0302 | 10 | 7.9 | 5 | 6.6 | 1.24 | 0.13 | > 0.75 |
| 0701/0702 | 46 | 36.5 | 15 | 19.7 | 2.37 | 6.33 | < 0.025 |
| 901 | 31 | 24.6 | 22 | 28.9 | 0.8 | 0.46 | > 0.50 |
| 1201/1202 | 17 | 13.5 | 12 | 15.8 | 0.85 | 0.2 | > 0.75 |
| 1501/1502 | 16 | 12.7 | 9 | 11.8 | 1.08 | 0.03 | > 0.90 |
| Blank | 19 | 15 | 8 | 10.5 | 1.51 | 0.85 | > 0.50 |
- Citation: Chu RH, Ma LX, Wang G, Shao LH. Influence of HLA-DRB1 alleles and HBV genotypes on interferon-α therapy for chronic hepatitis B. World J Gastroenterol 2005; 11(30): 4753-4757
- URL: https://www.wjgnet.com/1007-9327/full/v11/i30/4753.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i30.4753